Patents Assigned to ALGOTHERAPEUTIX
  • Topical pharmaceutical composition in the form of aqueous gel comprising at least amitriptyline
    Patent number: 12156854
    Abstract: The present invention relates to a topical pharmaceutical composition in the form of an aqueous gel comprising at least amitriptyline and/or a pharmaceutically acceptable salt thereof with a content between 10 and 30% by weight relative to the total weight of the composition, and water.
    Type: Grant
    Filed: April 30, 2024
    Date of Patent: December 3, 2024
    Assignee: ALGOTHERAPEUTIX
    Inventors: Paola Principe Nicolas, Frédéric Lallemand, Stéphane Thiroloix
  • Topical pharmaceutical composition in the form of aqueous gel comprising at least amitriptyline
    Patent number: 12150920
    Abstract: The present invention relates to a topical pharmaceutical composition in the form of an aqueous gel comprising at least amitriptyline and/or a pharmaceutically acceptable salt thereof with a content between 10 and 30% by weight relative to the total weight of the composition, and water.
    Type: Grant
    Filed: April 30, 2024
    Date of Patent: November 26, 2024
    Assignee: ALGOTHERAPEUTIX
    Inventors: Paola Principe Nicolas, Frédéric Lallemand, Stéphane Thiroloix
  • Topical pharmaceutical composition comprising at least amitriptyline, for the treatment of peripheral neuropathic pain
    Patent number: 12005034
    Abstract: The present disclosure relates to a pharmaceutical composition comprising from 10% to 30% by weight of amitriptyline or of a pharmaceutically acceptable salt or ester thereof, relative to the total weight of the composition, amitriptyline, for use in the topical treatment of chemotherapy-induced peripheral neuropathic pain.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: June 11, 2024
    Assignee: ALGOTHERAPEUTIX
    Inventor: Céline Gréco
  • TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AMITRIPTYLINE AND AN ALKALINE AQUEOUS PHASE
    Publication number: 20240041766
    Abstract: The present invention relates to a topical pharmaceutical composition in the form of an oil-in-water emulsion comprising an oily phase based on amitriptyline in its basic form and an alkaline aqueous phase. The invention also relates to a method for treating neuropathic pain or erythromelalgia comprising the topical application to the patient of a pharmaceutical composition according to the invention.
    Type: Application
    Filed: March 15, 2022
    Publication date: February 8, 2024
    Applicant: AlgoTherapeutix
    Inventors: Frédéric Lallemand, Philippe PICAUT
  • TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
    Publication number: 20230201138
    Abstract: A method of applying a topical treatment of chemotherapy-induced peripheral neuropathic pain with a pharmaceutical composition comprising from 10% to 30% by weight of amitriptyline or of a pharmaceutically acceptable salt or ester thereof, relative to the total weight of the composition, amitriptyline, for use in the topical treatment of.
    Type: Application
    Filed: February 17, 2023
    Publication date: June 29, 2023
    Applicant: ALGOTHERAPEUTIX
    Inventor: Céline Gréco
  • TOPICAL PHARMACEUTICAL COMPOSITION IN GEL FORM COMPRISING AT LEAST AMITRIPTYLINE FOR USE IN THE TREATMENT OF NEUROPATHIC PHANTOM LIMB PAIN
    Publication number: 20230103462
    Abstract: The present invention relates to a method for treating neuropathic phantom limb pain comprising the topical application of a pharmaceutical composition containing amitriptyline or one of the pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 29, 2022
    Publication date: April 6, 2023
    Applicant: AlgoTherapeutix
    Inventors: Nicolas Paola Principe, Frédéric Lallemand, Céline Greco, Stéphane Thiroloix
  • TOPICAL PHARMACEUTICAL COMPOSITION IN GEL FORM COMPRISING AT LEAST AMITRIPTYLINE FOR USE IN THE TREATMENT OF CORONAVIRUS-INDUCED NEUROPATHIC PAIN
    Publication number: 20230103300
    Abstract: The present invention relates to a method for treating coronavirus-induced neuropathic pain comprising the topical application of a pharmaceutical composition containing amitriptyline or one of the pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 29, 2022
    Publication date: April 6, 2023
    Applicant: AlgoTherapeutix
    Inventors: Nicolas Paola Principe, Frédéric Lallemand, Céline Greco, Stéphane Thiroloix
  • USE OF AMITRIPTYLINE AND/OR ONE OF THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS A PRESERVATIVE
    Publication number: 20220387594
    Abstract: The present invention relates to a method for the preservation of a pharmaceutical composition by adding amitriptyline and/or one of the pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 2, 2022
    Publication date: December 8, 2022
    Applicant: AlgoTherapeutix
    Inventors: Frédéric LALLEMAND, Philippe PICAUT
  • TOPICAL PHARMACEUTICAL COMPOSITION IN THE FORM OF AQUEOUS GEL COMPRISING AT LEAST AMITRIPTYLINE
    Publication number: 20220304949
    Abstract: The present invention relates to a topical pharmaceutical composition in the form of an aqueous gel comprising at least amitriptyline and/or a pharmaceutically acceptable salt thereof with a content between 10 and 30% by weight relative to the total weight of the composition, and water.
    Type: Application
    Filed: March 31, 2021
    Publication date: September 29, 2022
    Applicant: AlgoTherapeutix
    Inventors: Paola Principe Nicolas, Frédéric Lallemand, Stéphane Thiroloix
  • TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
    Publication number: 20200297663
    Abstract: The present disclosure relates to a pharmaceutical composition comprising from 10% to 30% by weight of amitriptyline or of a pharmaceutically acceptable salt or ester thereof, relative to the total weight of the composition, amitriptyline, for use in the topical treatment of chemotherapy-induced peripheral neuropathic pain.
    Type: Application
    Filed: June 10, 2020
    Publication date: September 24, 2020
    Applicant: ALGOTHERAPEUTIX
    Inventor: Céline Gréco
  • TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
    Publication number: 20200197326
    Abstract: The present invention relates to a pharmaceutical composition comprising from 10% to 30% by weight of amitriptyline or of a pharmaceutically acceptable salt or ester thereof, relative to the total weight of the composition, amitriptyline, for use in the topical treatment of chemotherapy-induced peripheral neuropathic pain.
    Type: Application
    Filed: April 18, 2018
    Publication date: June 25, 2020
    Applicant: ALGOTHERAPEUTIX
    Inventor: Céline Gréco